ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Instrumentation

Instrument maker RedShiftBio gets cash and new CEO

by Michael McCoy
February 8, 2020 | APPEARED IN VOLUME 98, ISSUE 6

 

The scientific-instrument maker RedShift BioAnalytics has raised $18 million in a series D fundraising round that included increased investment from Waters Corp. RedShiftBio says three major drug companies recently installed its infrared spectroscopy tool, used to measure tiny changes in protein structure. The Burlington, Massachusetts–based firm also hired a new CEO, Julien Bradley, a veteran of instrument firms like Thermo Fisher Scientific and Ahura Scientific.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment